Surgical and Bronchoscopic Lung Volume Reduction for Severe Emphysema: A Systematic Review and Network Meta-analysis

Overview

Journal Lung

Specialty Pulmonary Medicine

Date 2025 Jan 6

PMID 39762564

Authors

Shota Yamamoto

Nobuyuki Horita

Ryosuke Imai

Takayuki Niitsu

Affiliations

Soon will be listed here.

Abstract

Background: Along with lung volume reduction surgery (LVRS), bronchoscopic lung volume reduction is a treatment option for end-stage emphysema. However, comparisons among interventions remain insufficient.

Methods: We searched on PubMed, CENTRAL, Embase, and Web of Science. We included randomized controlled trials with outcomes measuring mid-term mortality within 6 months, changes in forced expiratory volume in one second (FEV), St. George's Respiratory Questionnaire (SGRQ), six-minute walk distance (6MWD) from baseline, adverse event related to procedures, and long-term mortality within 5 years. Bayesian network meta-analysis was performed. The certainty was assessed by CINeMA.

Results: Twenty-five randomized controlled trials involving 4,283 patients were included, identifying seven types of procedures and standard of care. Mid-term mortality increased in LVRS and endobronchial valve (EBV) (LVRS, risk ratio [RR] 3.26, 95% CrI 1.98-6.21, low certainty; EBV, RR 2.06 95% CrI 1.07-4.36, moderate certainty). LVRS showed the largest improvements: change in FEV (187.2 mL, 95% CrI 166.4-209.6), 6MWD (42.2 m, 95% CrI 33.2-50.5), and SGRQ (- 13.29 points, 95% CrI - 27.25-0.75). Among bronchoscopic procedures, high efficacy was noted in EBV and endobronchial coil (EBC) for FEV changes (EBV, 111.8 mL, 95% CrI 92.2-136.2; EBC, 74.1 mL, 95% CrI 47.6-101.7). Pneumothorax increased in these two procedures (EBV, RR 12.75, 95% CrI 5.52-35.48; EBC, RR 4.95, 95% CrI 1.12-40.90).

Conclusion: LVRS offers high efficacies but is accompanied by increased mid-term mortality. EBV and EBC also showed effectiveness; however, they increased pneumothorax, and EBV slightly increased mortality. For accurate assessment, long-term survival data of BLVR are needed.

References

Mannino D, Buist A . Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370(9589):765-73. DOI: 10.1016/S0140-6736(07)61380-4. View

Christenson S, Smith B, Bafadhel M, Putcha N . Chronic obstructive pulmonary disease. Lancet. 2022; 399(10342):2227-2242. DOI: 10.1016/S0140-6736(22)00470-6. View

Kosek V, Thiel B, Nikolova K, Al-Masri E, Begher C, Frank C . Lung volume reduction surgery: from National Emphysema Treatment Trial to non-intubated awake video-assisted thoracoscopic surgery. Ann Transl Med. 2020; 8(21):1468. PMC: 7723631. DOI: 10.21037/atm-20-6430. View

Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A . A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003; 348(21):2059-73. DOI: 10.1056/NEJMoa030287. View

Sciurba F, Ernst A, Herth F, Strange C, Criner G, Marquette C . A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010; 363(13):1233-44. DOI: 10.1056/NEJMoa0900928. View

Ninane V, Geltner C, Bezzi M, Foccoli P, Gottlieb J, Welte T . Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J. 2012; 39(6):1319-25. DOI: 10.1183/09031936.00019711. View

Shah P, Zoumot Z, Singh S, Bicknell S, Ross E, Quiring J . Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med. 2014; 1(3):233-40. DOI: 10.1016/S2213-2600(13)70047-X. View

Herth F, Valipour A, Shah P, Eberhardt R, Grah C, Egan J . Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med. 2016; 4(3):185-93. DOI: 10.1016/S2213-2600(16)00045-X. View

Shah P, Slebos D, Cardoso P, Cetti E, Voelker K, Levine B . Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet. 2011; 378(9795):997-1005. DOI: 10.1016/S0140-6736(11)61050-7. View

10.

Come C, Kramer M, Dransfield M, Abu-Hijleh M, Berkowitz D, Bezzi M . A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015; 46(3):651-62. PMC: 4826269. DOI: 10.1183/09031936.00205614. View

11.

Buttery S, Banya W, Bilancia R, Boyd E, Buckley J, Greening N . Lung volume reduction surgery endobronchial valves: a randomised controlled trial. Eur Respir J. 2023; 61(4). PMC: 10133584. DOI: 10.1183/13993003.02063-2022. View

12.

Xu W, Wang J, He X, Wang J, Wu D, Li G . Bronchoscopic lung volume reduction procedures for emphysema: A network meta-analysis. Medicine (Baltimore). 2020; 99(5):e18936. PMC: 7004743. DOI: 10.1097/MD.0000000000018936. View

13.

Iftikhar I, Schimmel M, Sardi A, Mehta I, Gonzalez E, Musani A . Bronchoscopic Lung Volume Reduction with Valves and Coils. A Network Meta-analysis. Ann Am Thorac Soc. 2020; 17(11):1468-1475. DOI: 10.1513/AnnalsATS.202002-151OC. View

14.

Hutton B, Salanti G, Caldwell D, Chaimani A, Schmid C, Cameron C . The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015; 162(11):777-84. DOI: 10.7326/M14-2385. View

15.

Donohue J . Minimal clinically important differences in COPD lung function. COPD. 2006; 2(1):111-24. DOI: 10.1081/copd-200053377. View

16.

Polkey M, Spruit M, Edwards L, Watkins M, Pinto-Plata V, Vestbo J . Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med. 2012; 187(4):382-6. DOI: 10.1164/rccm.201209-1596OC. View

17.

Jones P . St. George's Respiratory Questionnaire: MCID. COPD. 2006; 2(1):75-9. DOI: 10.1081/copd-200050513. View

18.

Rhodes K, Turner R, Higgins J . Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data. J Clin Epidemiol. 2014; 68(1):52-60. PMC: 4270451. DOI: 10.1016/j.jclinepi.2014.08.012. View

19.

Turner R, Jackson D, Wei Y, Thompson S, Higgins J . Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med. 2014; 34(6):984-98. PMC: 4383649. DOI: 10.1002/sim.6381. View

20.

Nikolakopoulou A, Higgins J, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M . CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020; 17(4):e1003082. PMC: 7122720. DOI: 10.1371/journal.pmed.1003082. View